Onset of leukocytoclastic vasculitis following covid-19 vaccination: case based comprehensive review

Stojanovic M, Barac A, Petkovic A, Vojvodic N, Odalovic S (2023) Large-vessel giant cell arteritis following COVID-19—what can HLA typing reveal? Diagnostics 13:484. https://doi.org/10.3390/diagnostics13030484

Article  PubMed  PubMed Central  Google Scholar 

Valero C, Baldivieso-Achá JP, Uriarte M et al (2022) Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature. Rheumatol Int 42:1643–1652. https://doi.org/10.1007/s00296-022-05153-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sagy I, Zeller L, Raviv Y, Porges T, Bieber A, Abu-Shakra M (2022) New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review. Rheumatol Int. 42:2261–2266. https://doi.org/10.1007/s00296-022-05203-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kouranloo K, Dey M, Elwell H, Nune A (2023) A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol Int 43:1221–1243. https://doi.org/10.1007/s00296-023-05283-9

Article  PubMed  PubMed Central  Google Scholar 

Izci Duran T, Turkmen E, Dilek M, Sayarlioglu H, Arik N (2021) ANCA-associated vasculitis after COVID-19. Rheumatol Int 41:1523–1529. https://doi.org/10.1007/s00296-021-04914-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mv P, Auanassova A, Yessirkepov M, Zimba O, Gasparyan AY, Kitas GD, Ahmed S (2023) New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome. Clin Rheumatol 42:2761–2775. https://doi.org/10.1007/s10067-023-06694-6-6

Article  PubMed  Google Scholar 

Nune A, Durkowski V, Pillay SS, Barman B, Elwell H (2023) New-onset Rheumatic immune-mediated inflammatory diseases following SARS-CoV-2 vaccinations until May 2023: a systematic review. Vaccines (Basel) 11:1571. https://doi.org/10.3390/vaccines11101571

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azzazi Y, Abdelkader HA, Khedr H, El-Komy MHM (2022) Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature. J Cutan Pathol 49:736–742. https://doi.org/10.1111/cup.14235

Article  PubMed  Google Scholar 

Shakoei S, Kalantari Y, Nasimi M, Tootoonchi N, Ansari MS (2022) Cutaneous manifestations following COVID-19 vaccination: a report of 25 cases. Dermatol Ther 35:e15651. https://doi.org/10.1111/dth.15651

Article  CAS  PubMed  PubMed Central  Google Scholar 

The use of the WHO-UMC system for standardised case causality assessment-1-The use of the WHO-UMC system for standardised case causality assessment Why causality assessment?

Abdelmaksoud A, Wollina U, Temiz SA, Hasan A (2022) SARS-CoV-2 vaccination-induced cutaneous vasculitis: report of two new cases and literature review. Dermatol Ther 35:e15458. https://doi.org/10.1111/dth.15458

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bostan E, Gulseren D, Gokoz O (2021) New-onset leukocytoclastic vasculitis after COVID-19 vaccine. Int J Dermatol 60:1305–1306. https://doi.org/10.1111/ijd.15777

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bencharattanaphakhi R, Rerknimitr P (2021) Sinovac COVID-19 vaccine-induced cutaneous leukocytoclastic vasculitis. JAAD Case Rep 18:1–3. https://doi.org/10.1016/j.jdcr.2021.10.002

Article  PubMed  PubMed Central  Google Scholar 

Fritzen M, Funchal GDG, Luiz MO, Durigon GS (2022) Leukocytoclastic vasculitis after exposure to COVID-19 vaccine. An Bras Dermatol 97:118–121. https://doi.org/10.1016/j.abd.2021.09.003

Article  PubMed  Google Scholar 

Ball-Burack MR, Kosowsky JM (2022) A case of leukocytoclastic vasculitis following SARS-COV-2 vaccination. J Emerg Med 63(2):e62–e65. https://doi.org/10.1016/j.jemermed.2021.10.005

Article  PubMed  Google Scholar 

Mohamed MMB, Wickman TJ, Fogo AB, Velez JCQ (2021) De novo immunoglobulin A vasculitis following exposure to SARS-CoV-2 immunization. Ochsner J. 21:95–401. https://doi.org/10.31486/toj.21.0083

Article  Google Scholar 

Badier L, Toledano A, Porel T (2021) IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19. Autoimmun Rev 20:102951. https://doi.org/10.1016/j.autrev.2021.102951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grossman ME, Appel G, Little AJ, Ko CJ (2022) Post-COVID-19 vaccination IgA vasculitis in an adult. J Cutan Pathol. https://doi.org/10.1111/cup.14168

Article  PubMed  Google Scholar 

Bostan E, Zaid F, Akdogan N, Gokoz O (2022) Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitis. J Cosmet Dermatol 21:51–53. https://doi.org/10.1111/dth.15458

Article  CAS  PubMed  Google Scholar 

Cohen SR, Prussick L, Kahn JS, Gao DX, Radfar A, Rosmarin D et al (2021) Leukocytoclastic vasculitis flare following the COVID-19 vaccine. Int J Dermatol 60:1032–1033. https://doi.org/10.1111/ijd.15623

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandhu S, Chand S, Bhatnagar A, Dabas R, Bhat S et al (2021) Possible association between IgA vasculitis and COVID-19. Dermatol Ther 34:e14551. https://doi.org/10.1111/dth.14551

Article  CAS  PubMed  Google Scholar 

Dicks AB, Gray BH (2022) Images in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster. Vasc Med 27:100–101. https://doi.org/10.1177/1358863X211055507

Article  CAS  PubMed  Google Scholar 

Jin WJ, Ahn SW, Jang SH, Hong SM, Seol JE et al (2022) Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination. J Dermatol 49:e34–e35. https://doi.org/10.1111/1346-8138.16212

Article  CAS  PubMed  Google Scholar 

Liang I, Swaminathan S, Lee AYS (2022) Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Clin Rheumatol 41:1611–1612. https://doi.org/10.1007/s10067-021-05948-5

Article  PubMed  Google Scholar 

Guzmán-Pérez L, Puerta-Peña M, Falkenhain-López D, Montero-Menárguez J, Gutiérrez-Collar C et al (2021) Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2. J Eur Acad Dermatol Venereol 35:e741–e743. https://doi.org/10.1111/jdv.17547

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahrigharahkoshan S, Gagnon LP, Mathieu S (2021) Cutaneous leukocytoclastic vasculitis induction following ChAdOx1 nCoV-19 vaccine. Cureus 13:e19005. https://doi.org/10.7759/cureus.19005

Article  PubMed  PubMed Central  Google Scholar 

Erler A, Fiedler J, Koch A, Heldmann F, Schütz A (2021) Leukocytoclastic vasculitis after vaccination with a SARS-CoV-2 vaccine. Arthritis Rheumatol 73:2188. https://doi.org/10.1002/art.41910

Article  PubMed  PubMed Central  Google Scholar 

Colia R, Rotondo C, Corrado A, Cantatore FP (2021) Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine. Rheumatol Adv Pract 5:rkab050. https://doi.org/10.1093/rap/rkab050

Article  PubMed  PubMed Central  Google Scholar 

Larson V, Seidenberg R, Caplan A, Brinster NK, Meehan SA et al (2021) Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID -19 vaccination. J Cutan Pathol 8(49):34–41.

留言 (0)

沒有登入
gif